BIO-TECHNE CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64.06 USD | +2.23% |
|
+3.12% | -16.98% |
| 04-26 | Bio-Techne Corporation and Novomol-Dx Announce Point-of-Care Ocular Biomarker Assay | CI |
| 04-23 | Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIO-TECHNE CORPORATION | Other Biotechnology & Medical Research | +2.23% | +3.12% | -16.98% | -18.30% | +31.43% | 10.07B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- TECH Stock
- Charts Bio-Techne Corporation
- Comparison Chart
